[go: up one dir, main page]

WO2003046194A1 - NOVEL α-GALACTOSYL-CONTAINING NON-REDUCING DISACCHARIDES AND PROCESS FOR PRODUCING THE SAME - Google Patents

NOVEL α-GALACTOSYL-CONTAINING NON-REDUCING DISACCHARIDES AND PROCESS FOR PRODUCING THE SAME Download PDF

Info

Publication number
WO2003046194A1
WO2003046194A1 PCT/JP2002/012215 JP0212215W WO03046194A1 WO 2003046194 A1 WO2003046194 A1 WO 2003046194A1 JP 0212215 W JP0212215 W JP 0212215W WO 03046194 A1 WO03046194 A1 WO 03046194A1
Authority
WO
WIPO (PCT)
Prior art keywords
reducing
producing
galactose
galactosidase
galactosyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/012215
Other languages
French (fr)
Japanese (ja)
Inventor
Masamichi Okada
Shigeharu Mori
Hiroyuki Hashimoto
Koki Fujita
Kozo Hara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amano Enzyme Inc
Ensuiko Sugar Refining Co Ltd
Bio Research Corp of Yokohama
Original Assignee
Amano Enzyme Inc
Ensuiko Sugar Refining Co Ltd
Bio Research Corp of Yokohama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amano Enzyme Inc, Ensuiko Sugar Refining Co Ltd, Bio Research Corp of Yokohama filed Critical Amano Enzyme Inc
Publication of WO2003046194A1 publication Critical patent/WO2003046194A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04Disaccharides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms

Definitions

  • the present invention relates to a novel non-reducing disaccharide containing a 0; -galactosyl group and a method for producing the same.
  • the present invention relates to a non-reducing disaccharide, and methods for their preparation including the novel alpha _ galactosyl groups, in particular, non-reducing disaccharide G a 1 ⁇ 1 - 1; . 3 G a 1 ( hereinafter , G a1 is galactose,) and G a1 ⁇ 1-1 ⁇ G1c (hereinafter, G1c is glucose) and a method for producing them.
  • G a 1 hereinafter , G a1 is galactose,
  • G1c is glucose
  • trehalose G1c ⁇ 1-1-G1c
  • heat and acid resistance It is known that there is little adverse effect on other materials in food processing and preservation, such as the amino acid / protein is not damaged by a single reaction. In addition, it has excellent properties as a food material, such as a strong inhibitory effect on starch aging, protein denaturation, and lipid sleep.
  • a carbohydrate having a non-reducing end with a galactosyl group is naturally known as the trisaccharide raffinose permeribose, which has strong bifidobacterial selective growth activity and anti-cariogenic activity, as well as immune cell activation.
  • Various physiological functions such as action, anti-cancer effect, and improvement effect on atopic dermatitis have been reported. (Seipura Motoi-: Japanese Cancer Society-(General Assembly Article), 40, 13 2 (1 981), Taizo Nakura et al .: Food Industry, 2.2.28, 29, 1999).
  • non-reducing disaccharide containing a monogalactosyl group can be synthesized, the above-mentioned properties of trehalose or the functions of raffinose and melibiose can be provided, and as a result, excellent food and pharmaceutical materials can be provided. Can be expected.
  • non-reducing disaccharides containing an ⁇ -galactosyl group have conventionally been only Galal-laGlc described in JP-A-10-308488, and other sugars There is no known quality.
  • the present invention is to provide a novel non-reducing disaccharide containing a galactosyl group, which is expected as a useful food material or pharmaceutical material, and to provide a simple production method thereof. Aim. Disclosure of the invention
  • the present invention relates to a non-reducing disaccharide represented by the following formula (1).
  • the non-reducing disaccharide is prepared by subjecting a galactose or a substance containing galactose to a hypergalactosidase derived from a microorganism to produce an oligosaccharide containing an ⁇ -galactosyl group by a dehydration condensation reaction. It can be produced by decomposing the reducing sugar in the sugar and then separating it.
  • ⁇ -galactosidase was derived from Aspergillus niger (A spergi 11 usniger) APC-9319 strain (deposit number: FE RM BP—7680) which has excellent dehydration condensation reaction activity. Can be used.
  • the decomposition of the reducing sugar in the oligosaccharide produced in the above-mentioned production method can be performed by alkali decomposition.
  • the present invention also relates to a non-reducing disaccharide represented by the following formula (2).
  • the non-reducing disaccharide is obtained by reacting a substance containing galactose and glucose with ⁇ -galactosidase derived from a microorganism to form an oligosaccharide containing a single galactosyl group by a dehydration condensation reaction.
  • ⁇ a1-1 ⁇ Ga1 can be produced by hydrolyzing the reducing sugar in the oligosaccharide and then separating the oligosaccharide.
  • Hi-galactosidase was derived from Aspergillus niger APC-9319 strain (deposit number: FE RM BP-7680) which has excellent dehydration condensation reaction activity. Can be used.
  • the hydrolysis of Galal to lj3Gal mixed in the above production method can be carried out with one galactosidase. Further, the decomposition of the reducing sugar in the oligosaccharide produced in the above-mentioned production method can be carried out by alcohol decomposition.
  • microorganisms that produce monogalactosidase include, but are not limited to, microorganisms such as the genus Aspergillus (A spergi 11 us), the genus Penicillium (Penici 11 ium), and the genus Trichoderma (Trichoderma).
  • Aspergillus molds include Aspergillus
  • Punorebenorerentus (A spergi 1 1 uspulverulentus), as a genus of the genus Penicillium, Penicillium 'Citrinanum Penicillium 1 enium citrinum), Henicirium-Manore Chilean (Penicilli um mu lticolor), As the Trichoderma fungi, Trichoderma's viride (T richodermaviride) is preferable, and among them, Aspergillus ⁇ Niger (A spergillusniger) power is more preferable.
  • Aspernoregizoles' nigers (Aseergii11 uSniger)
  • Aspernoreginoles niger Aspergir1 11 uSniger
  • APC-9319 strain is particularly preferred. This strain was obtained by the applicant based on the Bustust Treaty, the Patent Organism Depositary Center, National Institute of Advanced Industrial Science and Technology (IPOD, Japan). Deposit No. 1 No. 1 Central No. 6) and its deposit number is FE RM BP—7680 (transferred from domestic deposit to international deposit, original deposit date August 29, 2000, national deposit) Accession number F ERM P—1 800 3).
  • Conidium head spherical to radial, conidia (optical microscope): spherical to subspherical, smooth to slightly rough, conidia (electron microscopy): rough (with bumps), diameter (3.5 to 4)
  • Leachate little formation (transparent to brown), odor: almost none, sterigmata: two-stage, colony growth rate (malt extract agar medium, culture at 25 ° C):> 85 mm (7 days) Culture),> 85 mm '(cultured for 12 days), growth rate of colonies (deep cultivated agar medium, 25 ° C culture): 60-67 mm (cultured for 7 days), 65-73 mm (cultured for 7 days) 1 2 days culture), settlement 0212215 color (malt extract agar medium): black (front), colorless (back), settlement color (Vapeckeast agar): black to gray-black (front), talium-gray-yellow (back)
  • This strain is classified into Aspergillus' Niker, Aspergillus nilu, niger, var. Niger, based on the conidial shape, the sterigmata, and the color of the colony.
  • ⁇ - galactosidase produced by this strain has extremely high dehydration condensation activity, and Candidaguilliermondii (C andidaguilliermondii), which is known to have the highest catalytic activity of dehydration condensation reaction among ⁇ -galactosidases in the past.
  • An oligosaccharide containing an ⁇ -galatatosyl group can be produced at a high yield from ⁇ -galactosidase produced by the H-404 strain (deposit number: FERMP—11062) (WO 02 / 186 14), and correspondingly, the non-reducing disaccharide of the formula (1) or (2) can be produced in high yield.
  • Saccharomyces cerevisiae Ne S accharomycescervis ⁇ ae
  • Nono Tenoresu bacteria belonging to the genus Bacillus' Megateri ⁇ beam B acillusmegaterium
  • the solid culture medium may be wheat bran alone or wheat bran with various additives such as kinako, soybean flour, ammonium salt, nitrate, urea, glutamic acid, aspartic acid, polypeptone, corn steep liquor, meat.
  • Organic and inorganic nitrogen compounds such as extracts, yeast extracts, and protein hydrolysates can be appropriately added and used.
  • suitable inorganic salts can be added.
  • the microorganisms grow well and produce enzymes smoothly.
  • a carbon source starch or a carbohydrate such as a fraction thereof, roasted dextrin, processed starch, starch derivative, physically treated starch and a substance containing -starch or galactose can be used.
  • Specific examples include soluble starch, corn starch, potato starch, sweet potato starch, dextrin, amylopectin, amylose, galataose, lactose, raffinose, and the like. Can be used in combination of two or more.
  • Nitrogen sources include polypeptone, casein, meat extract, yeast extract, corn steep liquor or organic nitrogen source substances such as soybean or soybean meal extracts, ammonium sulfate, ammonium phosphate, etc.
  • Amino acids such as inorganic nitrogen compounds and glutamic acid can be used, and these can be used alone or in combination of two or more.
  • the inorganic salts include phosphates such as potassium phosphate and potassium phosphate, magnesium salts such as magnesium sulfate, calcium salts such as calcium chloride, and sodium salts such as sodium carbonate. Used alone or in combination of two or more.
  • the culture is carried out by stationary culture, and the culture is adjusted to pH 3 to 7, preferably 4 to 7, and the bacterial strain is inoculated into the culture. Incubate at 20-37 ° C for 1-10 days. After the cultivation, 1-galactosidase can be obtained from the culture extract as a crude enzyme precipitate by means such as ethanol precipitation.
  • the culture is performed under aerobic conditions such as shaking culture or aeration-agitation culture, and the medium is adjusted to a pH range of 4 to 10, preferably pH 5 to 8, and the temperature is adjusted.
  • the cells are cultured at a temperature in the range of 10 to 40 ° C, preferably 25 to 37 ° C, for 24 to 96 hours.
  • the cells can be removed by centrifugation or other appropriate solid-liquid separation means to obtain a culture supernatant.
  • the fungus The body can be treated physically or enzymatically to obtain a bacterial extract. Then, high-purity monogalactosidase can be obtained from these crude enzyme solutions by appropriately combining ammonium sulfate salting out, gel filtration, hydrophobic chromatography and the like.
  • the enzymes used for the production of oligosaccharides containing a galactosyl group include, in addition to the enzyme preparations obtained as described above, extracts in the case of solid culture, and extracts in the case of liquid culture. Alternatively, a culture supernatant or an intracellular extract can be used as it is as an enzyme preparation. If necessary, an enzyme purified by a known method can also be used. It is also possible to use the cells as they are as an enzyme preparation. Alternatively, ⁇ -galactosidase mixed with a commercially available enzyme preparation, for example, a cellulase preparation ⁇ protease preparation, can be used. In this case, the enzyme preparation can be used as it is, or a single galactosidase can be prepared from the enzyme preparation by various known methods. It can be used after purification.
  • these enzymes or cells that produce the enzymes can be immobilized and used in a continuous or batch-wise manner in the reaction.
  • the raw material used for the reaction of ⁇ -galactosidase to produce the non-reducing disaccharide of the formula (1) is galactose or a substance containing galactose.
  • specific examples include galactose and hydrolysates of galactose and other compounds containing galactose such as lactose. These can be used alone or in combination.
  • galactose there are not only commercial galatose, but also meribiose, mannino triose, raffinose, stachy, plante, benorenoscose, galactan, galactomannan, arabinogalactan, rhamnogalatatan, ⁇ -galactosyl group or ⁇ -galactol such as galactolipid, ferulated galactose, galactovitol, galactosylglycerol, galactinol, lactose, ratatitol, lactulose, galactoligosaccharide, etc. Natural or synthetic oligosaccharides, glycosides or polysaccharides containing sil groups
  • galactosidase ⁇ -galactosidase, ⁇ -galactosidase, monogalactosidase, etc.
  • galactose prepared from hydrolyzate with acid can be used.
  • hydrolyzate of a compound containing galactose examples include meribiose, mannino triose, raffinose, stachyose, planteose, verbascourse, galactan, galactomannan, arabinogalactan, rhamnogalactan, galactolipid, ferula oxidation.
  • ⁇ -galactose such as galactose, galactopinitol, galata tosyl glycerol, galactinol, lactose, ratatitol, lactulose, galata tori saccharide and the like; natural or synthetic oligos containing a 3-galact tosyl group; Those obtained by hydrolyzing sugars, glycosides or polysaccharides with enzymes (eg, 3-galactanase, ⁇ -galactosidase, ⁇ -galactosidase) or acids can be used as they are.
  • enzymes eg, 3-galactanase, ⁇ -galactosidase, ⁇ -galactosidase
  • Raw materials used for the reaction of ⁇ -galactosidase to produce the non-reducing disaccharide of the formula (2) include substances containing galactose and glucose. Specifically, a mixture of galactose and glucose is suitably used. Examples thereof include a mixture containing lactose and glucose, and a compound containing galactose and glucose at an appropriate ratio. Lactose hydrolyzate obtained by hydrolyzing inexpensive lactose with -galactosidase or an acid is preferably used as it is. The ratio of galactose to dulcose is not particularly limited.
  • Glucose that binds to galactose is not only commercially available glucose, but also starch, malto-oligosaccharide, isomaltoligo-sugar, nigerooligo-sugar, koji-oligosaccharide, cyclodextrin, trehalose, maltitol, cellulose, cellooligo-sugar , Or sophoro-oligo-sugar, laminario-oligo-sugar, gentio-oligosaccharide, etc.
  • Hydrolysis of natural or synthetic oligosaccharides, glycosides or fertility including enzymes, such as amylase, gnorecoamylase, cellulase, a-dalcosidase, ⁇ -g / recosidase, or acids Gnorecose prepared from the product can be used.
  • enzymes such as amylase, gnorecoamylase, cellulase, a-dalcosidase, ⁇ -g / recosidase, or acids Gnorecose prepared from the product can be used.
  • ⁇ -Galactosidase is essentially a hydrolase, but if the concentration of galactose in the substrate is increased, it will also catalyze the reverse dehydration reaction of the hydrolysis reaction. Therefore, when a single galactosidase is allowed to act on a high concentration of galactose, it has the following structural formula: ⁇ — (G a)) n (n is usually an integer of 2 to 10 and G a1 is galactose) It produces an oligosaccharide containing an ⁇ -galactosyl group in a composition in which a large number of oligosaccharides such as disaccharide, trisaccharide, and tetrasaccharide are mixed.
  • G al a l of non-reducing disaccharide of the formula of the present invention (1) -: L 0 G a Ui can manufacture by performing decomposition and separation of reducing sugars oligosaccharide obtained above.
  • the decomposition of the reducing sugar in the oligosaccharide can be carried out by alkali decomposition, for example, by adding an alkali such as sodium hydroxide or potassium hydroxide to the oligosaccharide.
  • Galal — 1 Oligosaccharides other than i3Gal are degraded.
  • the addition amount of alkali is preferably from 0.1 to 6. ON final concentration.
  • the separation operation can be performed using a known separation means such as ion exchange chromatography, reverse phase chromatography, activated carbon column chromatography, and gel filtration column chromatography, but activated carbon mouth chromatography is preferred. .
  • Galal-lj3Glc of the non-reducing disaccharide represented by the formula (2) of the present invention Hydrolyzes the mixed Galal-lj3Gal, and further decomposes and separates the reducing sugar in the ⁇ - (Gal) n-G1c oligosaccharide obtained above. It can be manufactured by performing.
  • the hydrolysis of 110 Gal can be performed using an enzyme, and the enzyme is preferably -galactosidase.
  • the amount of galactosidase to be added is appropriately determined in consideration of the conditions such as the origin and activity of the enzyme, which are appropriate for each enzyme.
  • Decomposition of reducing sugars in oligosaccharides can be carried out by alkali decomposition, for example, by adding alkaline water such as sodium hydroxide or hydroxylic power to oligosaccharides. By this decomposition operation, oligosaccharides other than Galal-1 / 3G1c are decomposed.
  • the added amount of the alkali is preferably 0.1 to 6. ON final concentration.
  • the separation operation can be performed using a known separation means such as ion exchange chromatography, reverse phase chromatography, activated carbon column chromatography, and gel filtration column chromatography, but activated carbon mouth chromatography is preferred.
  • the oligosaccharide containing an ⁇ -galactosyl group synthesized by the dehydration condensation reaction is again subjected to monogalactosidase.
  • the glycosyltransferase is also decomposed and the transglycosylation reaction occurs in parallel, so the transglycosylation also contributes to the synthesis of oligosaccharides containing a single galactosyl group.
  • the galactose bond position and the number of bonds of the produced compound, or the ratio of these compounds are affected by the composition of the raw material galactose and glucose, the origin of the enzyme used and the reaction conditions.
  • reaction conditions for ⁇ -galactosidase vary depending on the enzyme used, but the reaction ⁇ is in the range of 3.0 to 10.0, preferably 4.0 to 9.0.
  • the reaction temperature is desirably high in terms of solubility and reaction rate, and is usually in the range of 20 to 90 ° (preferably 40 to 80 ° C.). It usually varies from 1 to 150 hours, depending on the amount used.
  • the present invention is not limited to the above conditions or only the reaction mode.
  • the galactose-glucose precipitates in the reaction system, and the galactose-glucose is supersaturated. It may be in a state, and is usually used at a concentration of 5 to 110% (w / v), and preferably at a concentration of 50 to 110% (w / V).
  • FIG. 1 is a diagram showing a calibration curve when the molecular weight of ⁇ _galactosidase obtained by a production example in the best mode for carrying out the invention described below is measured by HPLC.
  • FIG. 2 is a view showing the results of measuring, by SDS-PAGE, the molecular weight of ⁇ _galactosidase obtained in a production example in the best mode for carrying out the invention described below.
  • FIG. 3 is a diagram showing a change over time of a dehydration condensation reaction using galactose as a raw material in the best mode for carrying out the invention described below.
  • BEST MODE FOR CARRYING OUT THE INVENTION
  • Reference Example 1 (Paranitrophyl 0; a method for measuring ⁇ -galactosidase activity using galactoside as a substrate)
  • One unit (U) of the enzymatic activity was defined as the amount of the enzyme that liberated 1 micole of paraditrophenol per minute under these conditions.
  • Reference Example 2 Measured activity of Hi-galactosidase using melibiose as substrate
  • the bran koji was crushed finely, 8 L of water was added thereto, and the mixture was extracted overnight at 4 ° C, and then filtered with a filter paper to obtain an extract filtrate.
  • the ⁇ -galactosidase activity of the obtained extract filtrate was measured, it was 3 units (U) per 1 ml of the extract filtrate.
  • 1 L of 6 L of extraction filtrate is filtered with an ultrafiltration membrane (SIP made by Asahi Kasei Corporation) Then, ammonium sulfate was added to achieve 70% saturation, and salting out was performed.
  • the precipitate was collected by centrifugation, dissolved in 500 ml of water, concentrated to 100 ml with an ultrafiltration membrane, and further added with 500 ml of water to 100 ml. After concentration, this operation was repeated three times to perform desalting. After desalting, freeze-drying was performed to obtain a freeze-dried powder (250 UZg).
  • Ammonium sulfate was added to the extract filtrate obtained above so as to be 70% saturated and stirred, and then left at 4 ° C. for a while.
  • the precipitate was collected by centrifugation, dissolved in 10 mM phosphate buffer (pH 6.0), concentrated with an ultrafiltration membrane (SIP manufactured by Asahi Kasei Corporation), and the buffer was reconstituted again. It was added and concentrated. This operation was repeated three times for desalting.
  • the a-galactosidase obtained above has the following physicochemical properties. 1 Action
  • G a1 a 1 OR represents a carbohydrate containing a single galactosyl group
  • G a 1 ⁇ H represents free galactose
  • R—OH represents various sugars, alcohols and Compounds having a hydroxyl group such as fuynols are shown.
  • meliviose acts on meliviose, raffinose, stachyose, etc., which have a single galactosyl group at the non-reducing end, and on paranitrophenyl ⁇ -galactoside. Assuming that the decomposition rate of para-trophenyl hyalgalactoside as a substrate is 100, the relative rate of decomposition of meliviose is about 9.
  • the optimal ⁇ ⁇ is 2.5 to 6.0.
  • the pH is stable in the range of 3.5 to 8.0.
  • the optimum temperature at pH 4.5 (acetate buffer) is 60 ° C. It is stable up to 60 ° C when left at pH 4.5 (acetate buffer) for 15 minutes.
  • the molecular weight measured by a gel filtration method using a YMC-Pack Dio 1 — 200 column is 2,170,000, and the molecular weight measured by SDS-PAGE is 1 17 , 00 0 (FIGS. 1 and 2).
  • the isoelectric point measured by isoelectric focusing is 4.2.
  • This enzyme can be used for a-galactosita produced by Aspergillus niger (A spergi 11 usniger), which has been reported so far, and for 72,000 and 69,000 (all SDS -It is characterized by a higher molecular weight compared to (PAGE).
  • Galactose manufactured by Wako Pure Chemical Industries, Ltd. 60 g and acetate buffer solution with a pH of 4.5 containing 2,100 U M of the galactosidase obtained in the production example 10 Om l (galactose concentration 6 0% (w / v) , enzyme concentration 3 5 U M - Gala click toast) was prepared and 3 0 hours reaction at 5 0 ° C.
  • Figure 3 shows the time course of the reaction.
  • the reaction solution was loaded on an activated carbon column, and oligosaccharide was eluted with water at a concentration gradient of galactose and ethyl alcohol of 0 to 30%.
  • the oligosaccharide-eluted fraction was concentrated and dried to obtain 24 g of an oligosaccharide containing an ⁇ -galactosyl group.
  • this oligosaccharide was hydrolyzed with monogalactosidase or acid, only galactose was formed.
  • ⁇ _galactosidases Candida gilli enolemon tea (C andidagui 11 iermondii) H-404 strain, which is known to have the highest catalytic activity of the dehydration condensation reaction, is used.
  • the yield was 14 g, a production example, and the yield of Hi-galactosidase obtained in this example was excellent.
  • Lactose (produced by Wako Pure Chemical Industries, Ltd.) 100 g is commercially available j3-galactosidase (Lactozym manufactured by Novozym Co., Ltd.) to obtain an equal mixture of galactose and glucose.
  • the oligosaccharide obtained above contains a mixture of Galal-l ⁇ Gal
  • 20 g of this oligo was added to 100 ml of 20 mM phosphate buffer to facilitate purification.
  • the solution was dissolved in a liquid (pH 6.5), and added with 45,000 LAU (unit of lactase from Novozym Co., Ltd.)], followed by addition of 3-galactosidase (Lactozym from Novozym Co., Ltd.). Further, 20 mM phosphate buffer (pH 6.5) was added to the solution so that the solution volume became S180 ml. This solution was treated at 40 ° C.
  • novel non-reducing disaccharides represented by the formulas (1) and (2) of the present invention may cause amino acids and proteins to be damaged by the Maillard reaction caused by the reaction between the amino compound and the reducing sugar. Since it is not available, it is expected as a food material that has little adverse effect on other materials in food processing and storage, and as a pharmaceutical material.
  • the novel method for producing a non-reducing disaccharide of the present invention is a method for producing a non-reducing disaccharide, which is derived from Aspergillus niger APC-9319 strain (FE RM BP-7680).
  • FE RM BP-7680 Aspergillus niger APC-9319 strain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Novel α-galactosyl-containing non-reducing disaccharides Galα1-1βGal and Galα1-1βGlc expected as useful food materials and medicinal materials which would not damage amino acids or proteins when added to foods or preserved. A process for producing the non-reducing disaccharide Galα1-1βGal which comprises treating galactose or a galactose-containing material with α-galactosidase, decomposing reducing sugars contained in the α-galactosyl-containing oligosaccharides thus obtained and separating the same; and a process for producing the non-reducing disaccharide Galα1-1βGlc which comprises starting with a material containing galactose and glucose, hydrolyzing Galα1-1βGal contained in the α-galactosyl-containing oligosaccharides obtained in the same manner as described above, decomposing the reducing sugars and separating the same.

Description

^ m -m  ^ m -m

新規な 0;—ガラク トシル基を含む非還元性二糖及びそれらの製造方法 技術分野  TECHNICAL FIELD The present invention relates to a novel non-reducing disaccharide containing a 0; -galactosyl group and a method for producing the same.

本発明は、 新規な α _ガラク トシル基を含む非還元性二糖及びそれら の製造方法に関し、 詳細には、 非還元性二糖の G a 1 α 1 - 1 ;3 G a 1 .(以下、 G a 1 はガラク ト一—ス,)と G a 1 α 1 - 1 β G 1 c (以下、 G 1 cはグルコース) 及びそれらの製造方法に関する。 背景技術 The present invention relates to a non-reducing disaccharide, and methods for their preparation including the novel alpha _ galactosyl groups, in particular, non-reducing disaccharide G a 1 α 1 - 1; . 3 G a 1 ( hereinafter , G a1 is galactose,) and G a1α1-1βG1c (hereinafter, G1c is glucose) and a method for producing them. Background art

近年 非還元性二糖の一種である トレハロ ース (G 1 c α 1— 1 ひ G 1 c ) は非還元性で耐熱 ·耐酸性に優れ、 ァミノ化合物と還元糖との 反応に起因するメイラ一ド反応によりアミノ酸ゃタンパク質が損なわれ ることがないなど、 食品の加工や保存において他の素材への悪影響が少 ないことが知られている。 また、 デンプンの老化、 タンパク質の変性、 脂質の睡化を抑制する作用も強い等、 食品素材として優れた性質を有し ている。 ' '  In recent years, trehalose (G1cα1-1-G1c), a type of non-reducing disaccharide, is non-reducing and has excellent heat and acid resistance. It is known that there is little adverse effect on other materials in food processing and preservation, such as the amino acid / protein is not damaged by a single reaction. In addition, it has excellent properties as a food material, such as a strong inhibitory effect on starch aging, protein denaturation, and lipid sleep. ''

一方、 ひ 一ガラク トシル基を非還元末端に有する糖質は、 天然には三 糖のラフィノースゃメリビオースが知られ、 強いビフィズス菌選択増殖 活性や抗ぅ蝕性の他に、 免疫铀胞活性化作用、 制がん効果、 アトピー性 皮膚炎の改善効果などの様々な生理機能が報告されている (本井重榭ら -: 日本癌学会 - (総会記事) , 4 0, 1 3 2 (1 9 8 1 ) 、 名倉泰三ら : 食品工業, . 2. 2 8, 2 9, 1 9 9 9) 。  On the other hand, a carbohydrate having a non-reducing end with a galactosyl group is naturally known as the trisaccharide raffinose permeribose, which has strong bifidobacterial selective growth activity and anti-cariogenic activity, as well as immune cell activation. Various physiological functions such as action, anti-cancer effect, and improvement effect on atopic dermatitis have been reported. (Seipura Motoi-: Japanese Cancer Society-(General Assembly Article), 40, 13 2 (1 981), Taizo Nakura et al .: Food Industry, 2.2.28, 29, 1999).

従って、 ひ 一ガラク トシル基を含む非還元性二糖を合成できれば、 上 述のト レハロースの有する諸性質あるいはラフィノースやメリビオース の有する諸機能を'備え、 ひいては優れた食品素材や医薬品素材の提 —供が期待できる。 しかしながら、 α—ガラク トシル基を含む非還元性二糖は、 従来、 特 開平 1 0— 3 0 4 8 8 1号公報に記載される G a l a l — l a G l cが あるのみであり、 その他の糖質については知られていない。 Therefore, if a non-reducing disaccharide containing a monogalactosyl group can be synthesized, the above-mentioned properties of trehalose or the functions of raffinose and melibiose can be provided, and as a result, excellent food and pharmaceutical materials can be provided. Can be expected. However, non-reducing disaccharides containing an α-galactosyl group have conventionally been only Galal-laGlc described in JP-A-10-308488, and other sugars There is no known quality.

そこで、 本発明は、 有用な食品素材や医薬品素材と して期待される新 規なひ 一ガラク トシル基を含む非還元性二糖を提供すること及びその簡 便な製造方法を提供することを目的とする。 発明の開示  Accordingly, the present invention is to provide a novel non-reducing disaccharide containing a galactosyl group, which is expected as a useful food material or pharmaceutical material, and to provide a simple production method thereof. Aim. Disclosure of the invention

本発明は、 下記式 (1 ) で表される非還元性二糖に関する。  The present invention relates to a non-reducing disaccharide represented by the following formula (1).

Figure imgf000004_0001
上記非還元性二糖は、 ガラク トース又はガラク トースを含む物質に微 生物に由来するひ —ガラク トシダーゼを作用ざせ、 脱水縮合反応により α—ガラク トシル基を含むオリゴ糖を生成させ、 該オリ ゴ糖中の還元糖 の分解後、 分離操作することにより製造できる。 この製造方法において、 α—ガラク トシダーゼは、 脱水縮合反応の活性に優れるァスペルギルス '二ガー (A s p e r g i 1 1 u s n i g e r ) A P C— 9 3 1 9株 (寄託番号 : F E RM B P— 7 6 8 0 ) 由来のものを用いることがで きる。 上記製造方法において生成するオリ ゴ糖中の還元糖の分解は、 ァ ルカリ分解により行うことができる。 また、 本発明は、 下記式 (2) で表される非還元性二糖に関する。
Figure imgf000004_0001
The non-reducing disaccharide is prepared by subjecting a galactose or a substance containing galactose to a hypergalactosidase derived from a microorganism to produce an oligosaccharide containing an α-galactosyl group by a dehydration condensation reaction. It can be produced by decomposing the reducing sugar in the sugar and then separating it. In this production method, α-galactosidase was derived from Aspergillus niger (A spergi 11 usniger) APC-9319 strain (deposit number: FE RM BP—7680) which has excellent dehydration condensation reaction activity. Can be used. The decomposition of the reducing sugar in the oligosaccharide produced in the above-mentioned production method can be performed by alkali decomposition. The present invention also relates to a non-reducing disaccharide represented by the following formula (2).

Figure imgf000005_0001
Figure imgf000005_0001

上記非還元性二糖は、 ガラク トースとグルコースを含む物質に微生物 に由来する α—ガラク トシダーゼを作用させ、 脱水縮合反応により ひ一 ガラク トシル基を含むオリ ゴ糖を生成させ、 混在する G Ά \ a 1 - 1 β G a 1 の加水分解、 さらに前記オリゴ糖中の還元糖の分解後、 分離操作 することにより製造できる。 この製造方法において、 ひ一ガラク トシダ ーゼは、 脱水縮合反応の活性に優れるァスペルギルス · 二ガー (A s p e r g i l l u s n i g e r ) AP C— 9 3 1 9株 (寄託番号 : F E RM B P— 7 6 8 0) 由来のものを用いることができる。 上記製造方 法において混在する G a l a l ~ l j3 G a lの加水分解は、 一ガラク トシダーゼにより行うことができる。 また、 上記製造方法において生成 するオリ ゴ糖中の還元糖の分解は、 アル力リ分解により行うことができ る。 The non-reducing disaccharide is obtained by reacting a substance containing galactose and glucose with α-galactosidase derived from a microorganism to form an oligosaccharide containing a single galactosyl group by a dehydration condensation reaction. \ a1-1 βGa1 can be produced by hydrolyzing the reducing sugar in the oligosaccharide and then separating the oligosaccharide. In this production method, Hi-galactosidase was derived from Aspergillus niger APC-9319 strain (deposit number: FE RM BP-7680) which has excellent dehydration condensation reaction activity. Can be used. The hydrolysis of Galal to lj3Gal mixed in the above production method can be carried out with one galactosidase. Further, the decomposition of the reducing sugar in the oligosaccharide produced in the above-mentioned production method can be carried out by alcohol decomposition.

ひ 一ガラク トシダーゼを生産する微生物と しては、 例えばァスペルギ ノレス (A s p e r g i 1 1 u s ) 属、 ぺニシリ ウム (P e n i c i 1 1 i u m) 属、 トリ コデルマ (T r i c h o d e r m a ) 属などの力ビ類、 サッカロマイセス (S a c c h a r o my c e s ) 属などの酵母類、 あ るいはバチルス (B a c i l l u s ) 属に属する細菌類等が挙げられる 力^ ァスペルギルス (A s p e r g i 1 1 u s ) 属に属する微生物由来 の α—ガラク トシダーゼが好ましい。 上記微生物の内、 ァスペルギルス属カビ類と しては、 ァスペルギルスExamples of microorganisms that produce monogalactosidase include, but are not limited to, microorganisms such as the genus Aspergillus (A spergi 11 us), the genus Penicillium (Penici 11 ium), and the genus Trichoderma (Trichoderma). Α-galactosidase derived from microorganisms belonging to the genus Aspergillus (A spergi 11 us), including yeasts such as the genus Saccharomyces and bacteria belonging to the genus Bacillus. Is preferred. Among the above microorganisms, Aspergillus molds include Aspergillus

' ニ^ー (A s p e r g i 1 1 u s n i g e rリ 、 ノ ス 'ニ (A sp er g i 1 1 u s n i g e r

オリゼ (A s p e r g i 1 1 u s o r y z a e ) 、 ァス z  Orize (A sp e r g i 1 1 u s o r y z a e), as z

プノレべノレレンタス (A s p e r g i 1 1 u s p u l v e r u l e n t u s ) , ぺニシリ ゥム属力ビ類としては、 ぺニシリ ゥム ' シトリナム P e n i c i 1 1 i u m c i t r i n u m) 、 へニシリ ウム -マノレ チカラ一 (P e n i c i l l i um mu l t i c o l o r ) 、 トリ コ デルマ属カビ類と しては、 トリコデルマ ' ビリデ (T r i c h o d e r m a v i r i d e ) が好ましく、 これらの中でもァスペルギルス ■ 二 ガー (A s p e r g i l l u s n i g e r ) 力 より好ましい。  Punorebenorerentus (A spergi 1 1 uspulverulentus), as a genus of the genus Penicillium, Penicillium 'Citrinanum Penicillium 1 enium citrinum), Henicirium-Manore Chilean (Penicilli um mu lticolor), As the Trichoderma fungi, Trichoderma's viride (T richodermaviride) is preferable, and among them, Aspergillus ■ Niger (A spergillusniger) power is more preferable.

ァスぺノレギゾレス ' 二ガー (A s e r g i 1 1 u s n i g e r ) の 中でも、 ァスぺノレギノレス · 二ガー (A s p e r g i 1 1 u s n i g e r ) AP C- 9 3 1 9株が特に好ましい。 本菌株は、 本出願人によりブ タぺス ト条約に基づき独立行政法人産業技術総合研究所特許生物寄託セ ンター ( I P OD、 〒 3 0 5— 8 5 6 6 日本国茨城県つくば巿東 1丁 目 1番地 1中央第 6 ) に寄託され、 その受託番号は F E RM B P— 7 6 80である (国内寄託から国際寄託に移管、 原寄託日 200 0年 8 月 2 9日、 国內寄託の受託番号 F ERM P— 1 8 00 3) 。  Among the Aspernoregizoles' nigers (Aseergii11 uSniger), the Aspernoreginoles niger (Aspergir1 11 uSniger) APC-9319 strain is particularly preferred. This strain was obtained by the applicant based on the Bustust Treaty, the Patent Organism Depositary Center, National Institute of Advanced Industrial Science and Technology (IPOD, Japan). Deposit No. 1 No. 1 Central No. 6) and its deposit number is FE RM BP—7680 (transferred from domestic deposit to international deposit, original deposit date August 29, 2000, national deposit) Accession number F ERM P—1 800 3).

本菌株について、 以下にその菌学的性質を記載する。  The bacterial properties of this strain are described below.

分生子頭 : 球状〜放射状、 分生子 (光学顕微鏡) : 球形〜亜球形、 滑 面〜やや粗面、 分生子 (電子顕微鏡) : 粗面 (隆起物がある) 、 直径 ( 3. 5〜4. 0 m程度) 、 浸出液: 少し形成 (透明〜褐色) 、 匂い : ほとんど無し、 ステリグマタ : 2段、 集落の発育速度 (麦芽エキス寒天 培地、 2 5 °C培養) : > 8 5 mm ( 7 日培養) 、 > 8 5 mm '( 1 2日培 養) 、 集落の発育速度 (ッァペックイース ト寒天培地、 2 5°C培養) : 6 0〜6 7mm ( 7 日培養) 、 6 5〜 7 3mm ( 1 2 日培養) 、 集落 0212215 の色調 (麦芽エキス寒天培地) : 黒色 (表面) 、 無色 (裏面) 、 集落の 色調 (ッァペックイース ト寒天培地) : 黒色〜灰黒色 (表面) 、 タリ ム色〜灰黄色 (裏面) Conidium head: spherical to radial, conidia (optical microscope): spherical to subspherical, smooth to slightly rough, conidia (electron microscopy): rough (with bumps), diameter (3.5 to 4) Leachate: little formation (transparent to brown), odor: almost none, sterigmata: two-stage, colony growth rate (malt extract agar medium, culture at 25 ° C):> 85 mm (7 days) Culture),> 85 mm '(cultured for 12 days), growth rate of colonies (deep cultivated agar medium, 25 ° C culture): 60-67 mm (cultured for 7 days), 65-73 mm (cultured for 7 days) 1 2 days culture), settlement 0212215 color (malt extract agar medium): black (front), colorless (back), settlement color (Vapeckeast agar): black to gray-black (front), talium-gray-yellow (back)

本菌株は、 分生子の形、 ステリグマタ及び集落の色調からァスペルギ ノレス ' 二カー 、 A s p e r g i l l u s n i g e r ) v a r . n i g e rに分類される。  This strain is classified into Aspergillus' Niker, Aspergillus nilu, niger, var. Niger, based on the conidial shape, the sterigmata, and the color of the colony.

この菌株が生産する α—ガラク トシダーゼは、 脱水縮合反応の活性が 極めて高く、 従来 α—ガラク トシダーゼの中でも脱水縮合反応の触媒活 性が最も高いことで知られるカンジダ■ ギリエルモンディ一 (C a n d i d a g u i l l i e r m o n d i i ) H- 4 0 4株 (寄託番号 : F E RM P— 1 1 0 6 2 ) の生産する α—ガラク トシダーゼより α—ガ ラタ トシル基を含むオリ ゴ糖が高収量で製造でき (WO 0 2/ 1 8 6 1 4参照) 、 これに対応して式 ( 1 ) 又は式 (2 ) の非還元性二糖を高収 量で製造できる。 Α- galactosidase produced by this strain has extremely high dehydration condensation activity, and Candidaguilliermondii (C andidaguilliermondii), which is known to have the highest catalytic activity of dehydration condensation reaction among α-galactosidases in the past. ) An oligosaccharide containing an α-galatatosyl group can be produced at a high yield from α-galactosidase produced by the H-404 strain (deposit number: FERMP—11062) (WO 02 / 186 14), and correspondingly, the non-reducing disaccharide of the formula (1) or (2) can be produced in high yield.

また、 サッカロマイセス属酵母としては、 サッカロマイセス · セレビ ンェ (S a c c h a r o m y c e s c e r v i s ι a e ) 、 ノヽテノレス 属細菌としては、 バチルス ' メガテリ ゥム (B a c i l l u s m e g a t e r i u m) 力 ¾ヌ于ましレヽ。 In addition, as the genus Saccharomyces yeast, Saccharomyces cerevisiae Ne (S accharomycescervis ι ae), as is Nono Tenoresu bacteria belonging to the genus Bacillus' Megateri © beam (B acillusmegaterium) force Mashi ¾ Nu Yu Rere.

上記の各微生物から α—ガラク トシダーゼを生産する方法は、 通常、 固体培養又は液体培養が用いられる。 固体培養の培地と しては、 小麦ふ すま単独あるいは小麦ふすまに種々の添加物、 例えば、 きな粉、 大豆粉、 アンモニゥム塩、 硝酸塩、 尿素、 グルタミン酸、 ァスパラギン酸、 ポリ ペプトン、 コーンスティープリカ一、 肉エキス、 酵母エキス、 タンパク 質加水分解物などの有機及び無機の窒素化合物などを適宜添加して用い ることができる。 さらに、 適当な無機塩類を加えることもできる。 また、 液体培養の培地と しては、 当該微生物が良好に成育し、 酵素を順調に生 産するために必要な炭素源、 窒素源、 無機塩、 必要な栄養源等を含有す る合成培地又は天然培地が挙げられる。 例えば、 炭素源としては、 澱粉 又はその組成画分、 焙焼デキス トリン、 加工澱粉、 澱粉誘導体、 物理処 理澱粉及び —澱粉あるいはガラク トースを含む物質等の炭水化物が使 用できる。 具体例としては、 可溶性澱粉、 トウモロコシ澱粉、 馬鈴薯澱 粉、 甘藷澱粉、 デキス ト リ ン、 アミロぺクチン、 アミロース、 ガラタ ト ース、 ラク トース、 ラフイノース等が挙げられ、 これらを単独で、 もし く は 2種以上を組み合わせて用いることができる。 窒素源と しては、 ポ リペプトン、 カゼイン、 肉エキス、 酵母エキス、 コーンスティープリカ —あるいは大豆又は大豆粕などの抽出物等の有機窒素源物質、 硫酸アン モ-ゥム、 リン酸アンモニゥム等の無機塩窒素化合物、 グルタ ミ ン酸等 のアミノ酸類が挙げられ、 これらを単独で、 もしくは 2種以上を組み合 わせて使用できる。 無機塩類と しては、 リン酸 1カリ ウム、 リン酸 2力 リ ウム等のリン酸塩、 硫酸マグネシウム等のマグネシウム塩、 塩化カル シゥム等のカルシウム塩、 炭酸ナトリ ウム等のナトリ ウム塩等を単独で、 あるいは 2種以上を組み合わせて用いられる。 As a method for producing α-galactosidase from each of the above microorganisms, solid culture or liquid culture is usually used. The solid culture medium may be wheat bran alone or wheat bran with various additives such as kinako, soybean flour, ammonium salt, nitrate, urea, glutamic acid, aspartic acid, polypeptone, corn steep liquor, meat. Organic and inorganic nitrogen compounds such as extracts, yeast extracts, and protein hydrolysates can be appropriately added and used. In addition, suitable inorganic salts can be added. In addition, as a culture medium for liquid culture, the microorganisms grow well and produce enzymes smoothly. A synthetic medium or a natural medium containing a carbon source, a nitrogen source, an inorganic salt, a necessary nutrient source, and the like necessary for production. For example, as the carbon source, starch or a carbohydrate such as a fraction thereof, roasted dextrin, processed starch, starch derivative, physically treated starch and a substance containing -starch or galactose can be used. Specific examples include soluble starch, corn starch, potato starch, sweet potato starch, dextrin, amylopectin, amylose, galataose, lactose, raffinose, and the like. Can be used in combination of two or more. Nitrogen sources include polypeptone, casein, meat extract, yeast extract, corn steep liquor or organic nitrogen source substances such as soybean or soybean meal extracts, ammonium sulfate, ammonium phosphate, etc. Amino acids such as inorganic nitrogen compounds and glutamic acid can be used, and these can be used alone or in combination of two or more. Examples of the inorganic salts include phosphates such as potassium phosphate and potassium phosphate, magnesium salts such as magnesium sulfate, calcium salts such as calcium chloride, and sodium salts such as sodium carbonate. Used alone or in combination of two or more.

固体培養の場合には、 静置培養で行い、 培地の p Hを 3〜 7、 好まし くは 4 ~ 7に調整したものに本菌を接種し、 1 0〜4 0.°C、 好ましくは 2 0 ~ 3 7 °Cで 1〜 1 0 日間培養を行う。 培養後、 その培養抽出物から ひ一ガラク トシダーゼをエタノール沈降などの手段により、 粗酵素沈殿 物と して得ることができる。  In the case of solid culture, the culture is carried out by stationary culture, and the culture is adjusted to pH 3 to 7, preferably 4 to 7, and the bacterial strain is inoculated into the culture. Incubate at 20-37 ° C for 1-10 days. After the cultivation, 1-galactosidase can be obtained from the culture extract as a crude enzyme precipitate by means such as ethanol precipitation.

また、 液体培養の場合、 培養は振盪培養もしくは通気撹拌培養等の好 気的条件下に行い、 培地を p H 4〜 1 0の範囲、 好ましくは p H 5〜 8 の範囲に調整し、 温度 1 0〜 4 0 °Cの範囲、 好ましくは、 2 5〜 3 7 °C で、 2 4〜 9 6時間培養する。 培養後、 遠心分離、 その他の適当な固一 液分離手段で菌体を除去し、 培養上清液を得ることができる。 また、 菌 体を物理的あるいは酵素的に処理し、 菌体内抽出液を得ることができる。 次いで、 これらの粗酵素液から硫安塩析処理法、 ゲル濾過処理、 疎水 クロマ トグラフィー処理などを適宜組み合わせることにより、 高純度の 一ガラク トシダーゼが得られる。 In the case of liquid culture, the culture is performed under aerobic conditions such as shaking culture or aeration-agitation culture, and the medium is adjusted to a pH range of 4 to 10, preferably pH 5 to 8, and the temperature is adjusted. The cells are cultured at a temperature in the range of 10 to 40 ° C, preferably 25 to 37 ° C, for 24 to 96 hours. After the culture, the cells can be removed by centrifugation or other appropriate solid-liquid separation means to obtain a culture supernatant. Also the fungus The body can be treated physically or enzymatically to obtain a bacterial extract. Then, high-purity monogalactosidase can be obtained from these crude enzyme solutions by appropriately combining ammonium sulfate salting out, gel filtration, hydrophobic chromatography and the like.

ひ 一ガラク トシル基を含むオリゴ糖の製造に用いる酵素と しては、 上 記のようにして得た酵素標品の他に、 固体培養の場合は、 その抽出液を、 液体培養の場合は、 培養上清液又は菌体内抽出液を、 そのまま酵素剤と して用いることができる。 また、 必要に応じて、 既知の方法で精製した 酵素も使用できる。 また、 菌体をそのまま酵素剤として利用することも 可能である。 あるいは市販酵素剤、 例えばセルラーゼ剤ゃプロテアーゼ 剤等に混在した α—ガラク トシダーゼも使用でき、 その場合、 酵素剤を そのまま使用するか、 あるいは酵素剤の中からひ一ガラク トシダーゼを 種々の既知方法で精製して使用することもできる。  The enzymes used for the production of oligosaccharides containing a galactosyl group include, in addition to the enzyme preparations obtained as described above, extracts in the case of solid culture, and extracts in the case of liquid culture. Alternatively, a culture supernatant or an intracellular extract can be used as it is as an enzyme preparation. If necessary, an enzyme purified by a known method can also be used. It is also possible to use the cells as they are as an enzyme preparation. Alternatively, α-galactosidase mixed with a commercially available enzyme preparation, for example, a cellulase preparation ゃ protease preparation, can be used. In this case, the enzyme preparation can be used as it is, or a single galactosidase can be prepared from the enzyme preparation by various known methods. It can be used after purification.

また、 これら酵素あるいは酵素を生産する菌体は、 固定化して連続式 で、 あるいはバッチ式で操り返し反応に利用することも可能である。  In addition, these enzymes or cells that produce the enzymes can be immobilized and used in a continuous or batch-wise manner in the reaction.

式 ( 1 ) の非還元性二糖を製造するために α _ガラク トシダーゼの反 応に供する原料は、 ガラク トース又はガラク トースを含む物質である。 具体的には、 ガラク トース、 ガラク トースと他の乳糖などのガラク ト ースを含む化合物の加水分解物などを挙げることができ、 これらを単独 で、 もしくは組み合わせて使用できる。 ガラク トースと しては市販のガ ラタ トースはもちろん、 メ リ ビオース、 マンニノ トリオース、 ラフイノ ース、 スタキ才ース、 プランテ才ース、 ベノレノ スコース、 ガラクタン、 ガラク トマンナン、 ァラビノガラクタン、 ラムノガラタタン、 ガラク ト リ ピド、 フェルラ酸化ガラク トース、 ガラク ト ビ二トール、 ガラク トシ ルグリセロール、 ガラクチノール、 乳糖、 ラタチトール、 ラクチュロー ス、 ガラク トオリゴ糖などの α—ガラク トシル基あるいは β —ガラク ト シル基を含む天然あるいは合成オリゴ糖、 配糖体あるいは多糖を酵素The raw material used for the reaction of α-galactosidase to produce the non-reducing disaccharide of the formula (1) is galactose or a substance containing galactose. Specific examples include galactose and hydrolysates of galactose and other compounds containing galactose such as lactose. These can be used alone or in combination. As galactose, there are not only commercial galatose, but also meribiose, mannino triose, raffinose, stachy, plante, benorenoscose, galactan, galactomannan, arabinogalactan, rhamnogalatatan, Α-galactosyl group or β-galactol such as galactolipid, ferulated galactose, galactovitol, galactosylglycerol, galactinol, lactose, ratatitol, lactulose, galactoligosaccharide, etc. Natural or synthetic oligosaccharides, glycosides or polysaccharides containing sil groups

( β —ガラクタう "一ゼ、 β —ガラク トシダーゼ、 一ガラク トシダーゼ など) あるいは酸を使用して加水分解したものから調製したガラク トー スを使用できる。 (β-galactosidase, β-galactosidase, monogalactosidase, etc.) or galactose prepared from hydrolyzate with acid can be used.

ガラク トースを含む化合物の加水分解物としては、 メ リビオース、 マ ンニノ ト リオース、 ラフィノース、 スタキオース、 プランテオース、 ベ ルバスコース、 ガラクタン、 ガラク トマンナン、 ァラビノガラクタン、 ラムノガラクタン、 ガラク トリ ピド、 フェルラ酸化ガラク トース、 ガラ ク トピ二 トール、 ガラタ トシルグリセ口ール、 ガラクチノール、 乳糖、 ラタチトール、 ラクチュロース、 ガラタ トオリ ゴ糖などの α—ガラク ト. シル基あるいは;3—ガラタ トシル基を含む天然あるいは合成オリ ゴ糖、 配糖体あるいは多糖を酵素 (/3—ガラクタナーゼ、 β —ガラク トシダー ゼ、 α—ガラク トシダーゼなど) あるいは酸を使用して加水分解したも のをそのまま使用できる。  Examples of the hydrolyzate of a compound containing galactose include meribiose, mannino triose, raffinose, stachyose, planteose, verbascourse, galactan, galactomannan, arabinogalactan, rhamnogalactan, galactolipid, ferula oxidation. Α-galactose such as galactose, galactopinitol, galata tosyl glycerol, galactinol, lactose, ratatitol, lactulose, galata tori saccharide and the like; natural or synthetic oligos containing a 3-galact tosyl group; Those obtained by hydrolyzing sugars, glycosides or polysaccharides with enzymes (eg, 3-galactanase, β-galactosidase, α-galactosidase) or acids can be used as they are.

式 (2 ) の非還元性二糖を製造するために α —ガラク トシダーゼの反 応に供する原料は、 ガラク トースとグルコースを含む物質が挙げられ、 具体的にはガラク トースとグルコースの混合物を適当な比率に混合した ものや乳糖などのガラク トースとグルコースを含む化合物を挙げられ、 安価な乳糖を —ガラク トシダーゼあるいは酸によって加水分解した乳 糖加水分解物をそのまま利用することが好ましい。 ガラク トースとダル コースの比率は特に制限されない。  Raw materials used for the reaction of α-galactosidase to produce the non-reducing disaccharide of the formula (2) include substances containing galactose and glucose. Specifically, a mixture of galactose and glucose is suitably used. Examples thereof include a mixture containing lactose and glucose, and a compound containing galactose and glucose at an appropriate ratio. Lactose hydrolyzate obtained by hydrolyzing inexpensive lactose with -galactosidase or an acid is preferably used as it is. The ratio of galactose to dulcose is not particularly limited.

ガラク トースとの結合の相手となるグルコースは、 市販のグルコース はもちろん、 澱粉、 マルトオリ ゴ糖、 イソマルトオリ ゴ糖、 ニゲロオリ ゴ糖、 コージオリゴ糖、 シクロデキス トリン、 トレハロース、 マルチト ール、 セルロース、 セロオリ ゴ糖、 ソホロオリ ゴ糖、 ラミナリオリ ゴ糖、 ゲンチォオリゴ糖などのひ 一ダルコシル基あるいは /3—ダルコシル基を 含む天然あるいは合成オリゴ糖、 配糖体あるいは多獰を酵素 (アミラー ゼ、 グノレコアミラーゼ、 セルラ一ゼ、 a一ダルコシダ一ゼ、 β —グ /レコ シダーゼなど) あるいは酸を使用して加水分解したものから調製したグ ノレコースを使用できる。 Glucose that binds to galactose is not only commercially available glucose, but also starch, malto-oligosaccharide, isomaltoligo-sugar, nigerooligo-sugar, koji-oligosaccharide, cyclodextrin, trehalose, maltitol, cellulose, cellooligo-sugar , Or sophoro-oligo-sugar, laminario-oligo-sugar, gentio-oligosaccharide, etc. Hydrolysis of natural or synthetic oligosaccharides, glycosides or fertility, including enzymes, such as amylase, gnorecoamylase, cellulase, a-dalcosidase, β-g / recosidase, or acids Gnorecose prepared from the product can be used.

α—ガラク トシダーゼは本来加水分解酵素であるが、 基質たる原料の ガラク トース濃度を高めれば、 加水分解反応の逆反応の脱水縮合反応も 触媒するようになる。 従って、 高濃度のガラク トースにひ 一ガラク トシ ダーゼを作用させた場合、 《— (G a 】 ) n (nは通常 2〜1 0の整数、 G a 1 はガラク トース) の構造式を有する 2糖、 3糖、 4糖等の多数の オリ ゴ糖が混在した組成物の α—ガラク トシル基を含むオリゴ糖を生成 する。  α-Galactosidase is essentially a hydrolase, but if the concentration of galactose in the substrate is increased, it will also catalyze the reverse dehydration reaction of the hydrolysis reaction. Therefore, when a single galactosidase is allowed to act on a high concentration of galactose, it has the following structural formula: << — (G a)) n (n is usually an integer of 2 to 10 and G a1 is galactose) It produces an oligosaccharide containing an α-galactosyl group in a composition in which a large number of oligosaccharides such as disaccharide, trisaccharide, and tetrasaccharide are mixed.

本発明の式 ( 1 ) の非還元性二糖の G a l a l — :L 0 G a Ui、 上記 で得られたオリゴ糖中の還元糖の分解及び分離操作を行うことにより製 造できる。 オリ ゴ糖中の還元糖の分解は、 アルカリ分解により行うこと ができ、 例えば水酸化ナトリウム、 水酸化カリ ウムなどのアルカリをォ リ ゴ糖に添加して行うことができ、 この分解操作により、 G a l a l — 1 i3 G a 1以外のオリ ゴ糖が分解される。 アルカ リの添加量は、 終濃度 0. 1 ~ 6. O Nが好ましい。 また、 分離操作は、 イオン交換クロマ ト グラフィー、 逆相クロマトグラフィー、 活性炭力ラムクロマトグラフィ 一、 ゲル濾過カラムクロマトグラフィーなど既知の分離手段を用いて行 うことができるが、 活性炭ク口マトグラフィ一が好ましい。 G al a l of non-reducing disaccharide of the formula of the present invention (1) -: L 0 G a Ui, can manufacture by performing decomposition and separation of reducing sugars oligosaccharide obtained above. The decomposition of the reducing sugar in the oligosaccharide can be carried out by alkali decomposition, for example, by adding an alkali such as sodium hydroxide or potassium hydroxide to the oligosaccharide. Galal — 1 Oligosaccharides other than i3Gal are degraded. The addition amount of alkali is preferably from 0.1 to 6. ON final concentration. The separation operation can be performed using a known separation means such as ion exchange chromatography, reverse phase chromatography, activated carbon column chromatography, and gel filtration column chromatography, but activated carbon mouth chromatography is preferred. .

ガラク トース以外に反応系にグルコースが存在すれば、 ガラク トース とグルコースが結合したひ一 (G a 1 ) n _G l c (nは通常;!〜 9の 整数、 G l cはグルコース) の構造式を有する α—ガラク トシル基を含 むオリゴ糖が生成し、 また G a 1 ひ 1一 l j3 G a 1 も混在する。  If glucose is present in the reaction system in addition to galactose, the structural formula of the combination of galactose and glucose (G a 1) n _G lc (where n is usually an integer from! To 9 and G lc is glucose) An oligosaccharide containing an α-galactosyl group is produced, and G a1 l 1 j3 G a1 is also present.

本発明の式 ( 2) で表される非還元性二糖の G a l a l - l j3 G l c は、 混在する G a l a l - l j3 G a l を加水分解し、 さらに上記で得ら れた α— (G a l ) n -G 1 cのオリ ゴ糖中の還元糖の分解及ぴ分離操 作を行うことにより製造できる。 G a l ひ 1 一 1 0 G a l の加水分解は、 酵素を用いて行うことができ、 酵素は —ガラク トシダーゼが好ましい。 Galal-lj3Glc of the non-reducing disaccharide represented by the formula (2) of the present invention Hydrolyzes the mixed Galal-lj3Gal, and further decomposes and separates the reducing sugar in the α- (Gal) n-G1c oligosaccharide obtained above. It can be manufactured by performing. The hydrolysis of 110 Gal can be performed using an enzyme, and the enzyme is preferably -galactosidase.

一ガラク トシダーゼの添加量は、 酵素の起源、 活性などそれぞれの 酵素に応じた条件を考慮して適宜決定する。 また、 オリ ゴ糖中の還元糖 の分解は、 アルカリ分解により行うことができ、 例えば水酸化ナトリ ウ ム、 水酸化力リ ゥムなどのアル力リをオリ ゴ糖に添加して行うことがで き、 この分解操作により、 G a l a l — 1 /3 G 1 c以外のオリゴ糖が分 解される。 アルカリの添加量は、 終濃度 0. 1〜6. O Nが好ましい。 分離操作は、 イオン交換クロマ トグラフィー、 逆相クロマトグラフィ 一、 活性炭カラムクロマトグラフィー、 ゲル濾過カラムクロマトグラフ ィーなど既知の分離手段を用いて行うことができるが、 活性炭ク口マト グラフィ一が好ましい。  The amount of galactosidase to be added is appropriately determined in consideration of the conditions such as the origin and activity of the enzyme, which are appropriate for each enzyme. Decomposition of reducing sugars in oligosaccharides can be carried out by alkali decomposition, for example, by adding alkaline water such as sodium hydroxide or hydroxylic power to oligosaccharides. By this decomposition operation, oligosaccharides other than Galal-1 / 3G1c are decomposed. The added amount of the alkali is preferably 0.1 to 6. ON final concentration. The separation operation can be performed using a known separation means such as ion exchange chromatography, reverse phase chromatography, activated carbon column chromatography, and gel filtration column chromatography, but activated carbon mouth chromatography is preferred.

なお、 上記 ( 1 ) 及び (2 ) の非還元性二糖の製造において、 酵素反 応が進むにつれ、 脱水縮合反応によって合成された α—ガラク トシル基 を含むオリ ゴ糖が再度 一ガラク トシダーゼによって分解され、 糖転移 反応も並行して起こるため、 糖転移反応もひ 一ガラク トシル基を含むォ リ ゴ糖の合成に寄与している。  In the production of the non-reducing disaccharides of the above (1) and (2), as the enzyme reaction proceeds, the oligosaccharide containing an α-galactosyl group synthesized by the dehydration condensation reaction is again subjected to monogalactosidase. The glycosyltransferase is also decomposed and the transglycosylation reaction occurs in parallel, so the transglycosylation also contributes to the synthesis of oligosaccharides containing a single galactosyl group.

また、 生成した化合物のガラク トースの結合位置、 結合数、 あるいは これらの化合物の比率は原料のガラク トースとグルコースの組成、 用い た酵素の由来や反応条件により影響を受ける。  In addition, the galactose bond position and the number of bonds of the produced compound, or the ratio of these compounds, are affected by the composition of the raw material galactose and glucose, the origin of the enzyme used and the reaction conditions.

α—ガラク トシダーゼの反応条件は、 用いる酵素により異なるが、 反 応 ρ Ηは 3. 0〜1 0. 0、 好ましくは 4. 0〜9. 0の範囲である。 反応温度は、 溶解度や反応速度の点から高い方が望ましく、 通常 2 0 〜9 0° ( 、 好ましくは 4 0〜8 0 °Cの範囲である。 反応時間は、 酵素の 使用量によって異なるが、 通常 1〜 1 5 0時間である。 しかしながら、 以上の条件、 あるいは反応形態のみに限定されるものではない。 The reaction conditions for α-galactosidase vary depending on the enzyme used, but the reaction ρΗ is in the range of 3.0 to 10.0, preferably 4.0 to 9.0. The reaction temperature is desirably high in terms of solubility and reaction rate, and is usually in the range of 20 to 90 ° (preferably 40 to 80 ° C.). It usually varies from 1 to 150 hours, depending on the amount used. However, the present invention is not limited to the above conditions or only the reaction mode.

さらに、 ひ 一ガラク トシル基を含むオリ ゴ糖を製造するには、 原料の ガラク トースの濃度は高い程良く、 ガラク トースゃグルコースは反応系 に析出しても、 また、 ガラク トースゃグルコースが過飽和状態でも良く、 通常 5〜 1 1 0 % (w/ v) の濃度で用い、 好ましくは 5 0〜 1 1 0 % (w/ V ) の濃度である。 図面の簡単な説明  Furthermore, in order to produce oligosaccharides containing a galactosyl group, the higher the concentration of the raw material galactose, the better.The galactose-glucose precipitates in the reaction system, and the galactose-glucose is supersaturated. It may be in a state, and is usually used at a concentration of 5 to 110% (w / v), and preferably at a concentration of 50 to 110% (w / V). BRIEF DESCRIPTION OF THE FIGURES

第 1図は、 以下に記述する発明を実施するための最良の形態における 製造例で得られた α _ガラク トシダーゼの分子量を HP L Cで測定した 際の検量線を示す図である。  FIG. 1 is a diagram showing a calibration curve when the molecular weight of α_galactosidase obtained by a production example in the best mode for carrying out the invention described below is measured by HPLC.

第 2図は、 以下に記述する発明を実施するための最良の形態における 製造例で得られた α _ガラク トシダーゼの分子量を S D S— PAGEで 測定した結果を示す図である。  FIG. 2 is a view showing the results of measuring, by SDS-PAGE, the molecular weight of α_galactosidase obtained in a production example in the best mode for carrying out the invention described below.

第 3図は、 以下に記述する発明を実施するための最良の形態における ガラク トースを原料とする脱水縮合反応の経時変化を示す図である。 以下、 本発明を図面を参照しながら説明する。 発明を実施するための最良の形態  FIG. 3 is a diagram showing a change over time of a dehydration condensation reaction using galactose as a raw material in the best mode for carrying out the invention described below. Hereinafter, the present invention will be described with reference to the drawings. BEST MODE FOR CARRYING OUT THE INVENTION

本発明を実施例を挙げて説明するが、 本発明は以下の実施例に限定さ れるものではない。  The present invention will be described with reference to examples, but the present invention is not limited to the following examples.

参考例 1 (パラニ トロフエ-ル0;—ガラク トシドを基質とする α—ガラ ク トシダーゼの活性測定法) Reference Example 1 (Paranitrophyl 0; a method for measuring α-galactosidase activity using galactoside as a substrate)

1 0 mMノヽ。ラニ トロフエ二ノレ α—ガラク トシド 0. 2m l と 4 0 mM の緩衝液 (ρ Hは酵素の至適 P Hに準じる) 0. 2m l に α—ガラタ ト シダーゼ溶液 0. 0 5m lを添加して、 4 0°Cにて 1 0分間反応させた。 反応後、 0. 2M炭酸ナトリ ウム 0. 5 m 1 を加えて反応を停止し、 遊離したパラ二ト口フユノール量を分光光度計にて 4 0 0 nmの吸光度 を計ることにより測定した。 酵素活性 1単位 (U) は、 この条件で 1分 間に 1マイク口モルのパラ二トロフエノールを遊離する酵素量とした。 参考例 2 (メ リビオースを基質とするひ 一ガラク トシダーゼの活性測定 法) 10 mM NO. Rani Torofue two Honoré α- galactosylceramide Toshido 0. 2m l and 4 0 mM buffer ([rho H are similar to that optimum PH for the enzyme) to 0. 2m l α - Galata DOO 0.05 ml of the sidase solution was added, and the mixture was reacted at 40 ° C. for 10 minutes. After the reaction, the reaction was stopped by adding 0.5 ml of 0.2 M sodium carbonate, and the amount of released pentanol was measured by measuring the absorbance at 400 nm with a spectrophotometer. One unit (U) of the enzymatic activity was defined as the amount of the enzyme that liberated 1 micole of paraditrophenol per minute under these conditions. Reference Example 2 (Measuring activity of Hi-galactosidase using melibiose as substrate)

1 0 mMメ リ ビオース 0. 2 m 1 と 40 mMの緩衝液 ( p Hは酵素の 至適 p Hに準じる) 0. 2 m 1に α—ガラク トシダーゼ溶液 0. 0 5m 1 を添加して、 4 0°Cにて 1 0分間反応させた。 次いで、 1 0 0°〇で1 0分間加熱して反応を停止させ、 生じたグルコース量をロシュ · ダイァ グノスティ ックス (株) 製の F—キッ ト (グルコース Zフルク トース) あるいは高速液体クロマトグラフィー (HP L C) により定量した。 酵素活性 1単位 (UM) は、 この条件下で 1分間に 1マイクロモルの グルコースを生成する酵素量とした。 10 mM melibiose 0.2 ml and 40 mM buffer (pH is based on the optimal pH of enzyme) Add 0.25 ml of α-galactosidase solution to 0.05 ml At 40 ° C. for 10 minutes. Next, the reaction was stopped by heating at 100 ° C. for 10 minutes to stop the reaction, and the amount of generated glucose was measured using Roche Diagnostics Co., Ltd. F-kit (glucose Z fructose) or high performance liquid chromatography ( HP LC). One unit of enzyme activity ( UM ) was defined as the amount of enzyme that produced 1 micromole of glucose per minute under these conditions.

製造例 ( ひ 一ガラク トシダーゼの製造) Production example (Production of Hi-ichi galactosidase)

5 %の小麦ふすまを含む液体培地 ( p H 6. 0) 9 0m lを 5 00m 1容坂ロフラスコに入れ、 常法によりオートク レープで殺菌後、 ァスぺ ルギルス ■ 二ガー AP C— 9 3 1 9株 (寄託番号: F E RM B P— 7 6 8 0 ) を接種して、 2 5°Cで 3 日間、 前培養 (種培養) を行った。 ふ すま 5 0 0 gに水 4 0 0 m lを添加して殺菌後、 前培養液 1 Om 1を接 種して良く撹拌した後、 2 5°Cにて 4日間、 本培養を行った。 培養後、 ふすま麹を細かく砕き、 水を 8 L添加して 4 °Cで一夜抽出した後、 濾紙 にて濾過して抽出濾過液を得た。 得られた抽出濾過液の α—ガラク トシ ダーゼ活性を測定したところ、 抽出濾過液 1 m 1当たり 3単位 (U) で あった。 抽出濾過液 6 Lを限外濾過膜 (旭化成 (株) 製 S I P) で 1 L まで濃縮し、 7 0 %飽和となるように硫酸アンモニゥムを添加して塩析 を行った。 続いて、 沈殿を遠心分離にて集め、 5 0 0 m 1の水に溶解し、 限外濾過膜で 1 0 0 m l まで濃縮し、 更に 5 0 0 m l の水を加えて 1 0 O m l まで濃縮し、 この操作を 3回繰り返し、 脱塩を行った。 脱塩後、 凍結乾燥を行い、 凍結乾燥粉末 ( 2 5 0 UZg) を得た。 90 ml of a liquid medium (pH 6.0) containing 5% wheat bran was placed in a 500 ml 1-volume flask, sterilized by autocrepe using a conventional method, and then subjected to Aspergillus. ■ Niger AP C—93 19 strains (deposit number: FE RM BP—7680) were inoculated and pre-cultured (seed culture) at 25 ° C. for 3 days. After adding 400 ml of water to 500 g of the bran and sterilizing, 1 Om1 of the preculture liquid was inoculated, stirred well, and then main-cultured at 25 ° C for 4 days. After the cultivation, the bran koji was crushed finely, 8 L of water was added thereto, and the mixture was extracted overnight at 4 ° C, and then filtered with a filter paper to obtain an extract filtrate. When the α-galactosidase activity of the obtained extract filtrate was measured, it was 3 units (U) per 1 ml of the extract filtrate. 1 L of 6 L of extraction filtrate is filtered with an ultrafiltration membrane (SIP made by Asahi Kasei Corporation) Then, ammonium sulfate was added to achieve 70% saturation, and salting out was performed. Subsequently, the precipitate was collected by centrifugation, dissolved in 500 ml of water, concentrated to 100 ml with an ultrafiltration membrane, and further added with 500 ml of water to 100 ml. After concentration, this operation was repeated three times to perform desalting. After desalting, freeze-drying was performed to obtain a freeze-dried powder (250 UZg).

上記で得られた抽出濾過液に 7 0 %飽和になるように硫酸アンモニゥ ムを添加して撹拌した後、 4 °Cにて一晚放置した。 その沈殿を遠心分離 にて集め、 1 0 mMのリン酸緩衝液 (p H 6. 0 ) に溶解した後、 限外 濾過膜 (旭化成 (株) 製 S I P ) で濃縮し、 再度同緩衝液を添加して濃 縮した。 この操作を 3回繰り返し、 脱塩を行った。  Ammonium sulfate was added to the extract filtrate obtained above so as to be 70% saturated and stirred, and then left at 4 ° C. for a while. The precipitate was collected by centrifugation, dissolved in 10 mM phosphate buffer (pH 6.0), concentrated with an ultrafiltration membrane (SIP manufactured by Asahi Kasei Corporation), and the buffer was reconstituted again. It was added and concentrated. This operation was repeated three times for desalting.

次に、 イオン交換クロマトグラフィーを行うために、 同緩衝液にて平 衡化した D E A E—トヨパール 6 5 0 M (東ソ一 (株) 製) カラムに供 した。 続いて、 疎水クロマトグラフィーを行うために、 5 0 %飽和硫酸 アンモニゥム中で、 プチルー ト ヨパール 6 5 0 M (東ソ一 (株) 製) 力 ラムに供した。 活性画分を集めて、 ゲル濾過クロマトグラフィーを行う ために、 0. 3 Mの塩化ナトリ ウムを含む 5 0 mM酢酸緩衝液 ( p H 5. 5 ) にて平 衡化したトョパール HW— 5 5 S (東ソ一 (株) 製) カラ ムに供した。 これらのカラムクロマトによりタンパク質的に均一な a— ガラク トシダーゼを得た。  Next, in order to perform ion-exchange chromatography, the sample was applied to a column of DAE-Toyopearl 65 M (manufactured by Tosoichi Co.) equilibrated with the same buffer. Subsequently, in order to perform hydrophobic chromatography, it was subjected to a petroleum yopal 650 M (manufactured by Tosoh I) in 50% saturated ammonium sulfate. The active fractions were collected and subjected to gel filtration chromatography. Topearl HW-55 was equilibrated with 50 mM acetate buffer (pH 5.5) containing 0.3 M sodium chloride. S (manufactured by East Souichi Co., Ltd.) These column chromatographs gave proteinaceous a-galactosidase.

上記で得られた a—ガラク トシダーゼは、 以下の理化学的性質を有する。 ①作用 The a-galactosidase obtained above has the following physicochemical properties. ① Action

a—ガラク トシド結合を加水分解して D—ガラク トースを遊離する反 応を触媒する。  Catalyzes the reaction that hydrolyzes a-galactoside bonds to release D-galactose.

G a 1 α 1 - O R + H20→G a 1 - O H+ R - O H G a 1 α 1-OR + H 20 → G a 1-O H + R-OH

(式中、 G a 1 a 1 一 O Rはひ一ガラク トシル基を含む糖質を、 G a 1 一〇Hは遊離のガラク トースを、 R— OHは種々の糖、 アルコール及び フユノール類などのヒ ドロキシル基を有する化合物を示す。 ) (In the formula, G a1 a 1 OR represents a carbohydrate containing a single galactosyl group, G a 1〇H represents free galactose, and R—OH represents various sugars, alcohols and Compounds having a hydroxyl group such as fuynols are shown. )

②基質特異性  ② Substrate specificity

非還元末端にひ一ガラク トシル基を有するメ リ ビオース、 ラフイノー ス、 スタキオースなどや、 パラニトロフエニル α—ガラク トシドに作用 する。 パラ- トロフエ二ルひ ーガラク トシドを基質と した場合の分解速 度を 1 0 0 と した場合、 メ リビオースを分解する相対速度は約 9である  It acts on meliviose, raffinose, stachyose, etc., which have a single galactosyl group at the non-reducing end, and on paranitrophenyl α-galactoside. Assuming that the decomposition rate of para-trophenyl hyalgalactoside as a substrate is 100, the relative rate of decomposition of meliviose is about 9.

③至適 ρ Η及び ρ Η安定性 ③ Optimum ρ Η and ρ Η stability

至適 ρ Ηは 2. 5〜6. 0である。 また、 4 0°Cで 1時間放置した場 合、 p H 3. 5〜 8. 0の範囲で安定である。  The optimal ρ で is 2.5 to 6.0. When left at 40 ° C for 1 hour, the pH is stable in the range of 3.5 to 8.0.

④至適温度及び温度安定性  ④Optimum temperature and temperature stability

p H 4. 5 (酢酸緩衝液) における至適温度は 6 0°Cである。 また、 p H 4. 5 (酢酸緩衝液) で 1 5分間放置した場合、 6 0 °Cまで安定で ある。  The optimum temperature at pH 4.5 (acetate buffer) is 60 ° C. It is stable up to 60 ° C when left at pH 4.5 (acetate buffer) for 15 minutes.

⑤分子量及び等電点 ⑤Molecular weight and isoelectric point

YMC - P a c k D i o 1 — 2 0 0カラム ( (株) ヮイエムシィ 製) を用いたゲル濾過法で測定した分子量は 2 1 7, 0 00で、 SD S 一 PAGEで測定した分子量は 1 1 7, 00 0である (図 1及び図 2) 。 また、 等電点電気泳動法により測定した等電点は 4. 2である。  The molecular weight measured by a gel filtration method using a YMC-Pack Dio 1 — 200 column (manufactured by YMC) is 2,170,000, and the molecular weight measured by SDS-PAGE is 1 17 , 00 0 (FIGS. 1 and 2). The isoelectric point measured by isoelectric focusing is 4.2.

本酵素は、 これまでに報告されているァスペルギルス ' 二ガー (A s p e r g i 1 1 u s n i g e r ) の生産する a—ガラク トシタ、、ーゼの 7 2, 0 0 0及び 6 9 , 0 00 (いずれも S D S— P A G E ) に比べ、 分子量が大きいことに特徴を有する。  This enzyme can be used for a-galactosita produced by Aspergillus niger (A spergi 11 usniger), which has been reported so far, and for 72,000 and 69,000 (all SDS -It is characterized by a higher molecular weight compared to (PAGE).

実施例 1 (式 ( 1 ) の G a l oi l— l j3 G a l の製造) Example 1 (Production of G a l oi l— l j3 G a l of Formula (1))

ガラク トース (和光純薬工業 (株) 製) 6 0 gと製造例で得られたひ 一ガラク トシダーゼ 2, 1 0 0 UMを含む p H 4. 5の酢酸緩衝液 1 0 Om l (ガラク トース濃度 6 0 % (w/v ) 、 酵素濃度 3 5 UM—ガラ ク トース) を調製し、 5 0°Cにて 3 0時間反応させた。 反応の経時変化 を図 3に示す。 反応液を活性炭カラムに負荷し、 水にてガラク トース、 エチルアルコール 0〜 3 0 %の濃度勾配にてォリ ゴ糖を溶出した。 ォリ ゴ糖溶出画分を濃縮乾燥して α _ガラク トシル基を含むオリゴ糖を 2 4 g得た。 このオリゴ糖は、 ひ一ガラク トシダーゼあるいは酸で加水分解 すると、 ガラク トースのみ生成した。 なお、 α _ガラク トシダーゼの中 でも脱水縮合反応の触媒活性が最も高いことで知られるカンジダ■ ギリ エノレモンティー (C a n d i d a g u i 1 1 i e r m o n d i i ) H - 4 0 4株の生産するひ一ガラク トシダーゼを用いて上記と同様の条件 でオリゴ糖を製造したところ、 収量は 1 4 gで製造例であり、 本実施例 で得られたひ一ガラク トシダーゼの収量が優れていた。 Galactose (manufactured by Wako Pure Chemical Industries, Ltd.) 60 g and acetate buffer solution with a pH of 4.5 containing 2,100 U M of the galactosidase obtained in the production example 10 Om l (galactose concentration 6 0% (w / v) , enzyme concentration 3 5 U M - Gala click toast) was prepared and 3 0 hours reaction at 5 0 ° C. Figure 3 shows the time course of the reaction. The reaction solution was loaded on an activated carbon column, and oligosaccharide was eluted with water at a concentration gradient of galactose and ethyl alcohol of 0 to 30%. The oligosaccharide-eluted fraction was concentrated and dried to obtain 24 g of an oligosaccharide containing an α-galactosyl group. When this oligosaccharide was hydrolyzed with monogalactosidase or acid, only galactose was formed. It should be noted that, among α_galactosidases, Candida gilli enolemon tea (C andidagui 11 iermondii) H-404 strain, which is known to have the highest catalytic activity of the dehydration condensation reaction, is used. When oligosaccharides were produced under the same conditions as above, the yield was 14 g, a production example, and the yield of Hi-galactosidase obtained in this example was excellent.

次いで、 上記で得られたオリゴ糖 1 0 gを脱塩水 9 0 m lに溶解後、 2. 0 N水酸化ナトリ ウムを 1 0 m 1添加し、 1 0 0°Cで 3 0分処理し 還元糖のみを分解させた。 塩酸で中和後、 その処理液を活性炭カラムに 供し、 ピーク a を検出 ' 分取した。 得られたピーク a画分を1 H— NM R、 13 C— NMRで構造解析を行ったところ、 ピーク aは非還元性二糖 の G a l a l — l j3 G a l であることが確認された。 帰属データを表 1 に示す。 なお、 数値は T P Sを内部標準とした時の化学シフ ト値 ( δ ) を、 括弧内の数値は結合定数を記した。 Next, after dissolving 10 g of the oligosaccharide obtained above in 90 ml of deionized water, 10 ml of 2.0 N sodium hydroxide was added, and the mixture was treated at 100 ° C. for 30 minutes for reduction. Only sugar was degraded. After neutralization with hydrochloric acid, the treated solution was applied to an activated carbon column, and peak a was detected and fractionated. Structural analysis of the obtained peak a fraction by 1 H—NMR and 13 C—NMR confirmed that peak a was Galal—lj3Gal of a non-reducing disaccharide. The attribution data is shown in Table 1. The numerical values are chemical shift values (δ) when TPS is used as an internal standard, and the numerical values in parentheses are binding constants.

C-l C一 2 C一 3 C-4 C-5 C-6 H - 1 a一 -Gal (1- 1) 一 - 102.9 71.1 73.5 72.0 74.4 64.0 5.26 C-l C-1 2 C-1 3 C-4 C-5 C-6 H-1 a-1 -Gal (1-1) 1-102.9 71.1 73.5 72.0 74.4 64.0 5.26

(3.1Hz) β- -Gal 105.9 73.5 75.1 72.0 78.1 63.8 4.57  (3.1Hz) β- -Gal 105.9 73.5 75.1 72.0 78.1 63.8 4.57

(7.5Hz) 実施例 2 (式 ( 2) の G a l a l— l ]3 G l c の製造)  (7.5 Hz) Example 2 (Production of Galal-l] 3Glc of formula (2))

乳糖 (和光純薬 (株) 製) 1 0 0 gを市販の j3—ガラク トシダーゼ (ノボザィム (株) 製ラク トザィム) によって加水分解し、 ガラク トー ス とグルコースの等量混合物を得た。 このガラク トースとグルコース の等量混合物 8 5 g と上記の製造例で得られた α—ガラク トシダーゼ 1 , 5 0 0 UMを含むp H4. 5の酢酸緩衝液 1 00 m 1 (糖度 8 5 % (w/v ) 、 酵素濃度 3 5 UM/g—ガラク トース) を調製し、 5 0°C にて 8 7時間反応させた。 反応液から活性炭カラムク口マトグラフィ 一により α—ガラク トシル基を含むォリゴ糖 2 7 gを得た (カンジダ • =Tリエノレモンティー 、 C a n d i d a g u i l 丄 i e r m o n d i i ) H— 404由来のひーガラタ トシダーゼの場合は 1 6 g ) 。 この α—ガラク トシル基を含むオリ ゴ糖は、 酸や α—ガラク トシダーゼに より加水分解すると、 ガラク トースとグルコースのみ生成した。 Lactose (produced by Wako Pure Chemical Industries, Ltd.) 100 g is commercially available j3-galactosidase (Lactozym manufactured by Novozym Co., Ltd.) to obtain an equal mixture of galactose and glucose. P H4 containing the galactose and glucose in equal mixture 8 5 g and the α- galactosylceramide obtained in Production Example of Toshidaze 1, 5 0 0 U M. 5 acetate buffer 1 00 m 1 (Brix 8 5 % (w / v), enzyme concentration 3 5 U M / g- galactose) were prepared and reacted for 8 7 h at 5 0 ° C. 27 g of oligosaccharide containing an α-galactosyl group was obtained from the reaction mixture by activated carbon column chromatography (Candida • = T lienolemon tea, C andidaguil ier iermondii). 16 g). The oligosaccharide containing the α-galactosyl group was hydrolyzed with an acid or α-galactosidase to produce only galactose and glucose.

次いで、 上記で得られたオリゴ糖は G a l a l - l ^ G a lが混在 していることから、 精製を容易にするため本ォリ ゴ 2 0 gを 1 0 0m 1の 2 0 mMリン酸緩衝液 ( p H 6. 5 ) に溶解し、 4 5, 00 0 L AU (ノボザィム (株) ラクターゼ単位) となるように ] 3—ガラタ ト シダーゼ (ノボザィム (株) 製ラク トザィム) を添加し、 さらに液量 力 S 1 8 0 m 1 となるように 2 0 mMリン酸緩衝液 ( p H 6. 5 ) を添 力 [Iした。 この溶液を 4 0 °Cで 24時間処理し、 G a l a l— l ]3 G a 1 を D—ガラク トースに加水分解した。 さらに、 13—ガラク トシダー ゼ処理液に 2. 0 N水酸化ナトリ ウムを 20 m 1添加し、 1 0 0°Cで 3 0分加熱し還元糖のみを分解させた。 塩酸で中和後、 その処理液を 活性炭カラムに供し、 ピーク aを検出 '分取した。 得られたピーク a 画分を1 H— NMR、 13C— NMRで構造解析を行ったところ、 ピー ク aは非還元性二糖の G a l a l— l jS G l cであることが確認され た。 帰属データを表 2に示した。 なお、 数値は T P Sを内部標準とし た時の化学シフ ト値 ( δ ) を、 括弧内の数値は結合定数を記した。 表 2 Next, since the oligosaccharide obtained above contains a mixture of Galal-l ^ Gal, 20 g of this oligo was added to 100 ml of 20 mM phosphate buffer to facilitate purification. The solution was dissolved in a liquid (pH 6.5), and added with 45,000 LAU (unit of lactase from Novozym Co., Ltd.)], followed by addition of 3-galactosidase (Lactozym from Novozym Co., Ltd.). Further, 20 mM phosphate buffer (pH 6.5) was added to the solution so that the solution volume became S180 ml. This solution was treated at 40 ° C. for 24 hours to hydrolyze Gal-l] 3G a1 to D-galactose. Further, 20 ml of 2.0 N sodium hydroxide was added to the 13-galactosidase-treated solution, and the mixture was heated at 100 ° C for 30 minutes to decompose only the reducing sugar. After neutralization with hydrochloric acid, the treated solution was applied to an activated carbon column, and peak a was detected and fractionated. Structural analysis of the obtained peak a fraction by 1 H-NMR and 13 C-NMR confirmed that peak a was a non-reducing disaccharide, Galal-ljS Glc. The attribution data is shown in Table 2. The values are chemical shift values (δ) when TPS is used as an internal standard, and the values in parentheses are binding constants. Table 2

C-l C-2 C一 3 C一 4 C-5 C- 6 H-l α - -Ga l (1-

Figure imgf000019_0001
71.1 73.4 .72.0 74.3 64.0 5.25 Cl C-2 C-1 3 C-1 4 C-5 C-6 Hl α--Gal (1-
Figure imgf000019_0001
71.1 73.4 .72.0 74.3 64.0 5.25

(3.0Hz) β - - G 1 c 105.4 75.9 77.2 73.2 78.2 64.0. 4.63  (3.0Hz) β--G 1 c 105.4 75.9 77.2 73.2 78.2 64.0.4.63

(7.5Hz) 産業上の利用性 o  (7.5Hz) Industrial use o

本発明の式 ( 1 ) 及び式 (2) で表される新規な非還元性二糖は、 ァ ミノ化合物と還元糖との反応に起因するメイラ一ド反応によりアミノ酸 やタンパク質が損なわれることがないので、 食品の加工や保存において 他の素材への悪影響が少ない食品素材として期待され、 また、 医薬素材 として期待される。  The novel non-reducing disaccharides represented by the formulas (1) and (2) of the present invention may cause amino acids and proteins to be damaged by the Maillard reaction caused by the reaction between the amino compound and the reducing sugar. Since it is not available, it is expected as a food material that has little adverse effect on other materials in food processing and storage, and as a pharmaceutical material.

また、 本発明の新規な非還元性二糖の製造方法は、 ァスペルギルス · 二ガー (A s p e r g i 1 1 u s n i g e r ) A P C— 9 3 1 9株 (F E RM B P— 7 6 8 0) に由来するひ一ガラク トシダーゼを用いる ことにより、 上記の各非還元性二糖を高収量で製造でき、 しかもこの酵 素は有機発酵や種々の食品用酵素剤の給源として利用されており安全性 にも優れる。  In addition, the novel method for producing a non-reducing disaccharide of the present invention is a method for producing a non-reducing disaccharide, which is derived from Aspergillus niger APC-9319 strain (FE RM BP-7680). By using galactosidase, each of the above non-reducing disaccharides can be produced at a high yield, and the enzyme is used as a source of organic fermentation and various enzyme agents for foods, and is excellent in safety.

Claims

請求の範囲 The scope of the claims 1. 下記式 ( 1 ) で表されるひ —ガラク トシル基を含む非還元性二糖 c 1. Non-reducing disaccharide c containing a galactosyl group represented by the following formula (1):
Figure imgf000020_0001
Figure imgf000020_0001
2. ガラク トース又はガラク トースを含む物質に微生物に由来する α— ガラク トシダーゼを作用させ、 脱水縮合反応により α—ガラク トシル基 を含むオリ ゴ糖を生成させ、 該オリゴ糖中の還元糖の分解後、 分離操作 する請求の範囲第 1項記載の α—ガラク トシル基を含む非還元性二糖の 製造方法。 2. An α-galactosidase derived from a microorganism is allowed to act on galactose or a substance containing galactose, and an oligosaccharide containing an α-galactosyl group is generated by a dehydration condensation reaction, thereby decomposing the reducing sugar in the oligosaccharide. 2. The method for producing a non-reducing disaccharide containing an α-galactosyl group according to claim 1, which is followed by a separation operation. 3. α—ガラタ トシダーゼが、 ァスぺノレギノレス ■ 二ガー (A s p e r g i 1 1 s n i g e r ) に由来のものである請求の範囲第 2項記載の α—ガラ ク トシル基を含む非還元性二糖の製造方法。  3. The non-reducing disaccharide containing an α-galactosyl group according to claim 2, wherein the α-galata tosidase is derived from Aspernoreginoles niger (A spergi 11 sniger). Production method. 4. ひーガラタ トシダーゼが、 ァスペルギルス · 二ガー (A s p e r g i 1 1 u s n i g e r ) AP C— 9 3 1 9株 (寄託番号: F E RM B P - 7 6 8 0 ) 由来のものである請求の範囲第 3項記載の α—ガラク ト シル基を含む非還元性二糖の製造方法。  4. The claim 3 wherein the higarata tosidase is derived from Aspergillus niger (A spergi 11 usniger) AP C—93 19 strain (deposit number: FE RM BP-7680). The method for producing a non-reducing disaccharide containing an α-galactosyl group as described above. 5. オリ ゴ糖中の還元糖の分解が、 アルカ リを用いることを特徴とする 請求の範囲第 2項〜請求の範囲第 4項のいずれか記載の α _ガラク トシ ル基を含む非還元性二糖の製造方法。  5. A non-reducing composition comprising an α-galactosyl group according to any one of claims 2 to 4, wherein the reducing sugar in the oligosaccharide is decomposed using alkali. Production method of sex disaccharide. 6. アルカリが、 水酸化ナトリ ウムである請求の範囲第 5項記載のひ一 ガラク トシル基を含む非還元性二糖の製造方法。  6. The method for producing a non-reducing disaccharide containing a monogalactosyl group according to claim 5, wherein the alkali is sodium hydroxide. 7. 下記式 ( 2 ) で表される α—ガラク トシル基を含む非還元性二糖。
Figure imgf000021_0001
7. A non-reducing disaccharide containing an α-galactosyl group represented by the following formula (2).
Figure imgf000021_0001
8. ガラク トースとグルコースを含む物質に微生物に由来する α—ガラ ク トシダーゼを作用させ、 脱水縮合反応により α—ガラク トシル基を含 むオリ ゴ糖を生成させ、 混在する G a l a l - l ^ G a l の加水分解、 さらに前記オリ ゴ糖中の還元糖の分解後、 分離操作することを特徴とす る請求の範囲第 7項記載の α—ガラク トシル基を含む非還元性二糖の製 造方法。 8. Microbial α-galactosidase is applied to a substance containing galactose and glucose to produce oligosaccharides containing α-galactosyl group by a dehydration condensation reaction. 8. The method for producing a non-reducing disaccharide containing an α-galactosyl group according to claim 7, wherein the hydrolysis is carried out and then the reducing sugar in the oligosaccharide is decomposed. Method. 9. <¾—ガラク トシダーゼが、 ァスペルギルス ■ 二ガー (A s p e r g i 1 1 u s n i g e r ) に由来のものである請求の範囲第 8項記載の α—ガラク トシル基を含む非還元性二糖の製造方法。  9. The method for producing a non-reducing disaccharide containing an α-galactosyl group according to claim 8, wherein the <¾-galactosidase is derived from Aspergillus 2 niger (Aspergii11usniger). 1 0. α—ガラク トシダーゼが、 ァスペルギルス · 二ガー (A s p e r g i l l u s n i g e r ) AP C— 9 3 1 9株 (寄託番号: F E RM B P - 7 6 8 0 ) 由来のものである請求の範囲第 9項記載の α—ガラク トシル基を含む非還元性二糖の製造方法。  10. The claim according to claim 9, wherein the α-galactosidase is derived from Aspergillus niger (A spergillusniger) APC-9319 strain (deposit number: FE RM BP-7680). A method for producing a non-reducing disaccharide containing an α-galactosyl group according to the above. 1 1. 混在する G a l a l— l jS G a l の加水分解が、 β—ガラク トシ ダーゼにより行うことを特徴とする請求の範囲第 8項〜請求の範囲第 1 0項のいずれか記載のひ一ガラク トシル基を含む非還元性二糖の製造方 法。 1 1. The method according to any one of claims 8 to 10, wherein hydrolysis of the mixed Galal-ljSGal is performed by β-galactosidase. A method for producing a non-reducing disaccharide containing a galactosyl group. 1 2. オリ ゴ糖中の還元糖の分解が、 アルカリを用いることを特徴とす る請求の範囲第 8項〜請求の範囲第 1 1項のいずれかに記載の α—ガラ ク トシル基を含む非還元性二糖の製造方法。 1 2. The α-galactosyl group according to any one of claims 8 to 11, wherein the reducing sugar in the oligosaccharide is decomposed with an alkali. A method for producing a non-reducing disaccharide comprising: 1 3. アルカ リカ 、 水酸化ナトリ ウムである請求の範囲第 1 2項記載の ひ一ガラク トシル基を含む非還元性二糖の製造方法。 13. The method for producing a non-reducing disaccharide containing a monogalactosyl group according to claim 12, wherein the method is alkali alcohol or sodium hydroxide.
PCT/JP2002/012215 2001-11-26 2002-11-22 NOVEL α-GALACTOSYL-CONTAINING NON-REDUCING DISACCHARIDES AND PROCESS FOR PRODUCING THE SAME Ceased WO2003046194A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-359777 2001-11-26
JP2001359777A JP4328482B2 (en) 2001-11-26 2001-11-26 Method for producing non-reducing disaccharide containing α-galactosyl group

Publications (1)

Publication Number Publication Date
WO2003046194A1 true WO2003046194A1 (en) 2003-06-05

Family

ID=19170721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/012215 Ceased WO2003046194A1 (en) 2001-11-26 2002-11-22 NOVEL α-GALACTOSYL-CONTAINING NON-REDUCING DISACCHARIDES AND PROCESS FOR PRODUCING THE SAME

Country Status (2)

Country Link
JP (1) JP4328482B2 (en)
WO (1) WO2003046194A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006083091A (en) * 2004-09-15 2006-03-30 Univ Nagoya Method for producing trehalose-type disaccharide and derivative thereof, and novel trehalose-type disaccharide derivative

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023022A1 (en) * 1993-03-31 1994-10-13 Novo Nordisk A/S AN α-GALACTOSIDASE ENZYME
EP0841397A2 (en) * 1996-11-08 1998-05-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose phosphorylase, its preparation and uses
WO2002018614A1 (en) * 2000-08-30 2002-03-07 Amano Enzyme Inc. METHOD OF ELEVATING YIELD OF OLIGOSACCHARIDES CONTAINING α-GALACTOSYL AND ANTI-CANDIDA COMPOSITIONS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023022A1 (en) * 1993-03-31 1994-10-13 Novo Nordisk A/S AN α-GALACTOSIDASE ENZYME
EP0841397A2 (en) * 1996-11-08 1998-05-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose phosphorylase, its preparation and uses
WO2002018614A1 (en) * 2000-08-30 2002-03-07 Amano Enzyme Inc. METHOD OF ELEVATING YIELD OF OLIGOSACCHARIDES CONTAINING α-GALACTOSYL AND ANTI-CANDIDA COMPOSITIONS

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HASHIMOTO H. ET AL.: "Enzymatic synthesis of alpha-linked galactooligosaccharides using the reverse reaction of a cell-bound alpha-galactosidase from candida guilliermondii H-404", BIOSCI. BIOTECH. BIOCHEM., vol. 59, no. 2, 1995, pages 179 - 183, XP002965228 *
MINAMI Y. ET AL.: "Selectivity and efficiency of galactosyl-oligosaccharides by bifidobacteria", CHEM. PHARM. BULL., vol. 33, no. 2, 1985, pages 710 - 714, XP000617604 *
RONNOW T.E.C.L. ET AL.: "The use of O-glycosyl trichloroacetimidates in the synthesis of unsymmetrical trehalose analogues", TETRAHEDRON: ASYMMETRY, vol. 5, no. 11, 1994, pages 2109 - 2122, XP005068184 *

Also Published As

Publication number Publication date
JP2003160594A (en) 2003-06-03
JP4328482B2 (en) 2009-09-09

Similar Documents

Publication Publication Date Title
US5141858A (en) Method for the production of α(1→2) oligodextrans using Leuconostoc mesenteroides B-1299
EP1321527A1 (en) Method of elevating yield of oligosaccharides containing alpha-galactosyl and anti-candida compositions
JP2012016309A (en) Maltotriose-forming amylase, production method and use thereof
Perna et al. Microbial fructosyltransferase: production by submerged fermentation and evaluation of pH and temperature effects on transfructosylation and hydrolytic enzymatic activities
US5057418A (en) Process for the preparation of difructose dianhydride iii
JP5274700B2 (en) Method for producing oligosaccharide having aldonic acid residue at reducing end and having α1 → 6 glucoside bond or β1 → 6 glucoside bond
JP4439641B2 (en) Novel mannanase, its production and use
WO2003046194A1 (en) NOVEL α-GALACTOSYL-CONTAINING NON-REDUCING DISACCHARIDES AND PROCESS FOR PRODUCING THE SAME
JP2008167744A (en) Method for producing cyclodextran and method for producing cyclodextran synthase
JP4132297B2 (en) Method for producing oligosaccharide
Benattouche et al. Characterization of partially purified extracellular thermostable invertase by Streptococcus sp isolated from the date
JP4830031B2 (en) Transferase, sugar production method, glycoside production method, transferase production method
JP4161181B2 (en) Novel process for producing carbohydrates including cordierigosaccharides and nigerooligosaccharides, and cells and enzymes used therefor, and processes for producing the same
JP4759028B2 (en) Method for producing non-reducing disaccharide containing α-galactosyl group
JPH09168385A (en) New beta-glucosidase, its production and use
US5593869A (en) Method of manufacturing sugars by trehalase
WO1995034570A1 (en) Process for producing disaccharides and novel saccharides
JPH089972A (en) New deaminoneuraminidase and its production
JP3656762B2 (en) Manufacturing method of laminari triose
JP2001292791A (en) Method for producing n-acetyllactosmine
JP4197604B2 (en) Novel strain, novel α-glucosidase and method for producing the same
Zerva et al. Transglycosylation of Stevioside by a Commercial β-Glucanase with Fungal Extracted β-Glucans as Donors
JP4826824B2 (en) oligosaccharide
US5604128A (en) Isolated cultures of Pestalotiopsis funerea IFO 5427 and Pestalotiopsis negleta FERM BP-3501
JP3601618B2 (en) Method for producing laminaripentaose-producing enzyme

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CN US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase